Event-Free Survival at 12 Months Predicts Long-Term Outcomes in DLBCL Patients Receiving CAR-T Therapy
Fields of Study & Subjects
CAR-T cell therapy research
Lymphoma Diagnosis and Treatment
T-cell and B-cell Immunology
Publication details
- Journal / source
- Transplantation and Cellular Therapy
- Volume
- 32
- Issue
- 2
- Pages
- S382–S383
- Publication date
- 1 February 2026
- Language
- EN